Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Generic Drug Pricing Not Getting Worse, But Ghost of Headwinds Remain

David Steinberg is out with a cautious note on Teva, believing much of the outlook is priced into the stock.

Tesla Inc (TSLA): Should Investors “Stay Away” for Now?

Three Wall Street experts shed cautious light on this electric car giant- is Tesla better for consumers than investors?

Helios and Matheson Analytics Inc (HMNY): Long-Term Opportunity for Large, Attractive Recurring Revenue Business, Says Austin Moldow

Canaccord’s Austin Moldow sees no end in sight for rapid-fire gains from HMNY’s MoviePass following favorable management meetings.

Marinus Pharmaceuticals Inc (MRNS) Wins a Bull Thanks to Potential in Multiple Central Nervous System Indications

Mizuho’s Difei Yang approaches the biotech player as a new bull, angling for a whopping 204% in return potential for MRNS shares.

Facebook, Inc. (FB): The Bulls Are Getting Nervous

GBH Insights’ Daniel Ives does not leave the bullish camp- but believes Cambridge data scandal presents a “major test” to FB’s “golden” prospects.

General Electric Company (GE) Grows Hand in Hand with Malaysia’s Power Development Needs

General Electric Company’s (NYSE:GE) Power Services business today announced it signed a multiyear agreement (MYA) with Southern …

Here’s Why This Top Analyst Upgraded Roku Inc (ROKU) Stock

After a selloff, Oppenheimer’s top analyst Jason Helfstein upgraded Roku Inc (NASDAQ:ROKU), from Underperform to …